Evidence map›Paper›PMID 39005860›Full record

ArticleIndian journal of clinical biochemistry : IJCB2024

Association of Serum Adipsin Level with Insulin Resistance and Inflammatory Markers in Newly Diagnosed Type two Diabetes Mellitus Patients.

Somya Singh, Sartaj Hussain, Suraj Singh Yadav, Nitesh Pati Tiwari, Kauser Usman, Kamal Kumar Sawlani, Sanjay Khattri

Abstract read
In one paragraph

Article in Indian journal of clinical biochemistry : IJCB, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Somya Singh *Department of Pharmacology and Therapeutics, King George's Medical University, Lucknow, 226003 India.
Sartaj Hussain *Department of Pharmacology, All India Institute of Medical Science, Vijaypur, Jammu, 184120 India.
Suraj Singh Yadav *Department of Pharmacology and Therapeutics, King George's Medical University, Lucknow, 226003 India.
Nitesh Pati TiwariDepartment of Pharmacology Government Medical College, Badaun, 243601 India.
Kauser UsmanDepartment of Medicine, King George's Medical University, Lucknow, 226003 India.
Kamal Kumar SawlaniDepartment of Medicine, King George's Medical University, Lucknow, 226003 India.
Sanjay KhattriDepartment of Pharmacology and Therapeutics, King George's Medical University, Lucknow, 226003 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipsin is an anti-inflammatory adipokines and its altered level was seen in obesity and type II DM. Our study investigated the clinical significance of serum adipsin levels as a risk marker for type 2 diabetes and its relationships with insulin resistance and various adipo-cytokines. The study included 110 treatment-naïve T2DM cases and 100 controls of similar age and gender from northern India. Clinical, biochemical, and anthropometric characteristics were all profiled. Serum adipo-cytokines were measured using ELISA methods. Adipsin was significantly inversely correlated with body mass index (BMI), waist circumference, fasting plasma glucose, glycated haemoglobin (HbA1C), total cholesterol (TC), triglyceride (TG), homeostasis model assessment-estimated insulin resistance (HOMA-IR), tumour necrosis factor- Graphical Abstract:

Indexed as

AdipsinHOMA-IRIL-6TNF-αType II diabetes mellitus

Identifiers

PMID39005860
PMCPMC11239611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.